| Meredith B Horne, | |
|
2250 Hickory Rd Ste 240, Plymouth Meeting, PA 19462-2225 | |
| (610) 834-1122 | |
| Not Available |
| Full Name | Meredith B Horne |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2250 Hickory Rd Ste 240, Plymouth Meeting, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003325408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL002463L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Meredith B Horne, 553 Patrice Ln, West Chester, PA 19380-3947 Ph: (610) 430-0251 | Meredith B Horne, 2250 Hickory Rd Ste 240, Plymouth Meeting, PA 19462-2225 Ph: (610) 834-1122 |
News Archive
Researchers from CNRS, INSERM and Toulouse University Hospital have demonstrated how the parasite Plasmodium falciparum, which causes severe forms of malaria, is able to circumvent the action of artemisinin and its derivatives, which are today the first-line drugs used to treat this disease. This study supplies some important findings that will enable a clearer understanding of the mechanisms of resistance to antimalarial drugs and the testing of novel therapeutic strategies in a context where the drug resistance of parasites is of increasing concern.
If you are a parent, chances are you have used or will use a baby gate at some point. Baby gates are designed to help protect young children from stairs and other dangers around the home. If you use these in your home, take note. A new study from researchers in the Center for Injury Research and Policy at Nationwide Children's Hospital has found gates can lead to injury if used incorrectly.
A federal appeals court has ruled that while a controversial abortion law is decided in court, Texas can enforce a law that requires women who are seeking an abortion to be presented with a sonogram.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tapentadol extended release (ER) tablets, an investigational oral analgesic for the management of moderate to severe chronic pain in patients 18 years of age or older.
› Verified 4 days ago
Cherie Levy Roche, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 | |
Burnetta Swartz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Mrs. Kristin Sears-kopp, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 800-879-4471 | |
Ms. Vicki Lynn Meitus, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 502 W Germantown Pike, Suite 200, Plymouth Meeting, PA 19462 Phone: 610-825-9360 | |
Ann Elizabeth Bollenbach, MED CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Road, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 Fax: 610-834-7525 | |
Mrs. Mila Marie Capuano, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |